https://www.octagam.com/Summary-of-Product-Characteristics https://www.octagam.com/about-octagam https://www.octagam.com/_common/downloads/downloads https://www.octagam.com/Summary-of-Product-Characteristics/safety-information-octagam-10 https://www.octagam.com/efficacy-and-tolerability/dermatomyositis https://www.octagam.com/dosing-and-infusion https://www.octagam.com/Summary-of-Product-Characteristics/safety-information-octagam-5 https://www.octagam.com/efficacy-and-tolerability https://www.octagam.com/manufacturing-and-safety https://www.octagam.com/indications https://www.octagam.com/ https://www.octagam.com/efficacy-and-tolerability/dermatomyositis/managing-dermatomyositis https://www.octagam.com/efficacy-and-tolerability/primary-immunodeficiency-PID https://www.octagam.com/efficacy-and-tolerability/dermatomyositis/the-proderm-study https://www.octagam.com/efficacy-and-tolerability/secondary-immunodeficiency-SID https://www.octagam.com/efficacy-and-tolerability/dermatomyositis/safety-and-tolerability-in-dermatomyositis https://www.octagam.com/efficacy-and-tolerability/chronic-inflammatory-demyelinating-polyneuropathy-CIDP https://www.octagam.com/efficacy-and-tolerability/dermatomyositis/dosing-and-rate-of-administration-in-dermatomyositis https://www.octagam.com/efficacy-and-tolerability/multifocal-motor-neuropathy-MMN https://www.octagam.com/efficacy-and-tolerability/immune-thrombocytopenia-itp https://www.octagam.com/privacy-statement https://www.octagam.com/legal-statement